Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel · Delayed Price · Currency is ILS · Price in ILA 79.90
-6.70 (-7.74%)
Jun 8, 2026, 5:24 PM IDT
Novolog (Pharm-Up 1966) Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3.55 | 4.12 | 39.54 | -42 | 47.51 | 42.32 |
Depreciation & Amortization | 58.91 | 57.67 | 57.18 | 103.98 | 44.55 | 38.48 |
Other Amortization | 19.26 | 19.26 | 9.9 | - | - | - |
Loss (Gain) From Sale of Assets | -0.06 | -0.16 | -0.13 | 0.14 | -0.34 | -0.53 |
Loss (Gain) on Equity Investments | -1.06 | -1.26 | 0.44 | 30.64 | 4.61 | 1.64 |
Stock-Based Compensation | 3.39 | 3.7 | 3.2 | -0.16 | 2.35 | 2.58 |
Other Operating Activities | -2.54 | -6.83 | 15.07 | 0.67 | 15.84 | 15.47 |
Change in Accounts Receivable | 554.59 | 717.17 | -188.74 | -242.32 | -7.35 | -14.65 |
Change in Inventory | 132.62 | 59.91 | -67.97 | -57.43 | -2.16 | 69.51 |
Change in Accounts Payable | -635.85 | -868.59 | 277.86 | 418.31 | 41.17 | -60.47 |
Change in Income Taxes | 0.38 | -2.53 | 1.35 | -5.63 | -11.08 | -3.85 |
Change in Other Net Operating Assets | 37.74 | 16.82 | 10.83 | -6.19 | -2.45 | -7.11 |
Operating Cash Flow | 170.92 | -0.73 | 158.52 | 200.01 | 132.65 | 83.39 |
Operating Cash Flow Growth | 171.68% | - | -20.75% | 50.79% | 59.08% | 42.58% |
Capital Expenditures | -17.78 | -17.72 | -13.39 | -36.25 | -44.97 | -30.64 |
Sale of Property, Plant & Equipment | 0.21 | 0.31 | 0.31 | 0.18 | 0.97 | 2.52 |
Cash Acquisitions | - | - | - | -9.71 | -50.9 | -19.02 |
Sale (Purchase) of Intangibles | -36.37 | -44.84 | -45.34 | -34.71 | -24.52 | - |
Investment in Securities | - | - | - | -3.1 | -11.93 | -26.71 |
Other Investing Activities | 4.74 | 5.8 | 10.13 | 10.98 | 6.41 | 4.78 |
Investing Cash Flow | -49.2 | -56.44 | -50.55 | -72.6 | -124.95 | -69.07 |
Short-Term Debt Repaid | - | - | - | -0.07 | - | - |
Long-Term Debt Repaid | - | -26.02 | -26.94 | -23.54 | -18.79 | -28.97 |
Total Debt Repaid | -26.57 | -26.02 | -26.94 | -23.61 | -18.79 | -28.97 |
Net Debt Issued (Repaid) | -26.57 | -26.02 | -26.94 | -23.61 | -18.79 | -28.97 |
Issuance of Common Stock | - | - | - | - | - | 119.83 |
Common Dividends Paid | -20 | -20 | -40 | -16.9 | -31.9 | -32 |
Other Financing Activities | -25.8 | -21.25 | -27.65 | -27.2 | -22.27 | -11.37 |
Financing Cash Flow | -72.37 | -67.27 | -94.59 | -67.71 | -72.96 | 47.49 |
Foreign Exchange Rate Adjustments | 3.37 | 3.54 | 1.28 | 0.44 | -0.64 | 0.46 |
Miscellaneous Cash Flow Adjustments | -0.75 | -4.94 | - | - | - | - |
Net Cash Flow | 51.98 | -125.83 | 14.66 | 60.13 | -65.9 | 62.27 |
Free Cash Flow | 153.14 | -18.45 | 145.12 | 163.77 | 87.68 | 52.75 |
Free Cash Flow Growth | 203.96% | - | -11.38% | 86.79% | 66.21% | 60.48% |
Free Cash Flow Margin | 8.49% | -1.02% | 7.18% | 9.96% | 5.81% | 4.20% |
Free Cash Flow Per Share | 0.30 | -0.04 | 0.28 | 0.32 | 0.17 | 0.10 |
Cash Interest Paid | 18 | 18 | 11.42 | 11.25 | 11.44 | 7.62 |
Cash Income Tax Paid | 18.27 | 22.97 | 18.3 | 22.07 | 33.8 | 19 |
Levered Free Cash Flow | 119.1 | -69.78 | 85.03 | 156.96 | 38.37 | 27.94 |
Unlevered Free Cash Flow | 132.86 | -57.74 | 92.91 | 165 | 46.2 | 33.23 |
Change in Working Capital | 89.48 | -77.23 | 33.32 | 106.74 | 18.13 | -16.57 |